Thromb Haemost 1991; 65(04): 451
DOI: 10.1055/s-0038-1648169
Letter to the Editor
Schattauer GmbH Stuttgart

DDAVP Does not Induce the Release of Thrombomodulin from Endothelial Cells

Hoyu Takahashi
First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
,
Wataru Tatewaki
First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
,
Ken Wada
First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
,
Hiroe Niwano
First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
,
Masaharu Hanano
First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
,
Jiro Tsubouchi
*   Mitsubishi Gas Chemical Company, Inc. Niigata, Japan
,
Toshio Nagai
*   Mitsubishi Gas Chemical Company, Inc. Niigata, Japan
,
Akira Shibata
First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 10. August 1990

Accepted after revision 13. November 1990

Publikationsdatum:
02. Juli 2018 (online)

 
  • References

  • 1 Esmon NL. Thrombomodulin. Prog Hemostas Thromb 1989; 9: 29-55
  • 2 Dittman WA, Majerus PW. Structure and function of thrombomodulin: A natural anticoagulant. Blood 1990; 75: 329-336
  • 3 Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-2181
  • 4 Mannucci PM. Desmopressin: A nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449-1455
  • 5 Ishii H, Nakano M, Tsubouchi J, Ishikawa T, Uchiyama H, Hiraishi S, Tahara C, Miyajima Y, Kazama M. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemostas 1990; 63: 157-162
  • 6 Lethagen S, Harris AS, Sjorin E, Nilsson IM. Intranasal and intravenous administration of desmopressin: Effect on F VIII/vWF, pharmacokinetics and reproducibility. Thromb Haemostas 1987; 58: 1033-1036
  • 7 Kazama M. Clinical evaluation of hemostatic molecular markers. Acta Haematol Jpn 1988; 51: 1387-1394
  • 8 Uchiyama H, Hiraishi S, Ohtani H, Ishii H, Kazama M. Plasma thrombomodulin is originated by damage of endothelial cell. Thromb Haemostas 1989 62. 276 (Abstr)